Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, sees markets in a "digestion phase" following the ...

Roger Altman, former deputy Treasury secretary and founder of Evercore, joins CNBC's 'Squawk Box' to discuss president-elect ...

Evercore ISI analyst Mark Lipacis raised the firm’s price target on Nvidia (NVDA) to $190 from $189 and keeps an Outperform rating on the shares. The firm continues to view Nvidia as a top pick post ...

The Federal Reserve appears to be heading to a more wary and “hedged posture” on the rate and level of further rate cuts due ...

Saudi Aramco's digital arm is in talks to take a significant minority stake in Mavenir, in a deal that is likely to value the ...

The deal by Aramco Digital would be its first major transaction in the telecommunications industry as part of Saudi Arabia’s ...

Evercore ISI initiated coverage of Edgewise Therapeutics (EWTX) with an Outperform rating and $45 price target The pipeline offers two “compelling assets” with multiple, near-term clinical readouts: ...

We recently compiled a list of the 15 AI News You Must Read Today. In this article, we are going to take a look at where ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 7th ...

Investors interested in meeting with Apnimed at the conference should contact their Evercore representative directly.

Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives ...

On Thursday, Evercore ISI updated its financial outlook on Snowflake Inc . (NYSE:SNOW), raising the price target to $190 from the previous $170 while maintaining an Outperform rating on the stock. The ...